BIOSPECIMEN REPOSITORY AND HISTOLOGY SERVICE SHARED RESOURCE PROJECT SUMMARY/ABSTRACT The Biospecimen Repository and Histology Service shared resource (Biorepository) of the Rutgers Cancer Institute of New Jersey (CINJ) is a Cancer Center managed shared resource whose purpose is to support transdisciplinary and translational research through cost-effective, quality controlled tissue collection, biospecimen procurement and processing and cancer clinical trial support. The Biorepository provides tissues for cancer research through a seamless acquisition-processing-distribution pathway. The resource staff also provides collection, processing and shipping for thousands of clinical trial specimens by adhering to specific protocols. Our CLIA licensed histology laboratory delivers state of the art technologies for tissue analysis along with professional tissue examination by board-certified pathologists. The Biorepository follows best practices as dictated by the College of American Pathologists (CAP) guidelines. The Biorepository uses state of the art technologies for tissue analysis and professional interpretation under CAP guidelines. In addition, the Biorepository serves as an ?honest broker? and maintains the chain of custody for patient samples and their clinical annotations. The Biorepository is comprised of three Divisions: 1) the Clinical Trial Laboratory, 2) the Banking Group and 3) the Histopathology Service. The Biorepository Lab Divisions support clinical trials, tissue banking and basic science by collecting, cataloging, processing, storing and distributing bio-specimens from human subjects while archiving useful medical information along with written patient consents. Each of the divisions is distinct, yet they cooperate to provide a seamless workflow and unparalleled service, and are operated by highly qualified technologists and strong leadership.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA072720-22
Application #
10112861
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-03-01
Project End
2024-02-29
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
22
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Rbhs -Cancer Institute of New Jersey
Department
Type
DUNS #
078728091
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Deek, Matthew P; Kim, Sinae; Ahmed, Inaya et al. (2018) Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung Cancer. Am J Clin Oncol 41:362-366
O'Malley, Denalee; Dewan, Asa A; Ohman-Strickland, Pamela A et al. (2018) Determinants of patient activation in a community sample of breast and prostate cancer survivors. Psychooncology 27:132-140
Park, Kihan; Chen, Wenjin; Chekmareva, Marina A et al. (2018) Electromechanical Coupling Factor of Breast Tissue as a Biomarker for Breast Cancer. IEEE Trans Biomed Eng 65:96-103
Jang, Thomas L; Patel, Neal; Faiena, Izak et al. (2018) Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer. Cancer 124:4010-4022
Gupta, Apar; Ohri, Nisha; Haffty, Bruce G (2018) Hypofractionated radiation treatment in the management of breast cancer. Expert Rev Anticancer Ther 18:793-803
Patrizii, Michele; Bartucci, Monica; Pine, Sharon R et al. (2018) Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy. Front Oncol 8:23
Herman, Joseph M; Jabbour, Salma K; Lin, Steven H et al. (2018) Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation. Pancreas 47:208-212
CeliĆ -Terrassa, Toni; Bastian, Caleb; Liu, Daniel et al. (2018) Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability. Nat Commun 9:5005
Zloza, Andrew (2018) Viruses, bacteria, and parasites - oh my! a resurgence of interest in microbial-based therapy for cancer. J Immunother Cancer 6:3
George, Blessy; Joy, Melanie S; Aleksunes, Lauren M (2018) Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy. Exp Biol Med (Maywood) 243:272-282

Showing the most recent 10 out of 775 publications